Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Deepak Kilari MD

Deepak Kilari MD

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center


Publications

  • Autologous Transplantation for Male Germ Cell Tumors: Improved Outcomes over 3 decades. (Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P) Biol Blood Marrow Transplant 2019 Feb 19 PMID: 30794931 02/23/2019    
  • Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients. (Kohli M, Li J, Du M, Hillman DW, Dehm SM, Tan W, Carlson R, Campion MB, Wang L, Wang L, Zhang H, Zhang P, Kilari D, Huang CC, Wang L) Prostate Cancer Prostatic Dis 2018 09;21(3):411-418 PMID: 29858592 PMCID: PMC6126974 06/03/2018       1 Citations
  • Immune Checkpoint Inhibitor-Associated Type 1 Diabetes Mellitus: Case Series, Review of the Literature, and Optimal Management. (Kapke J, Shaheen Z, Kilari D, Knudson P, Wong S) Case Rep Oncol 2017 Sep-Dec;10(3):897-909 PMID: 29279690 PMCID: PMC5731100 12/28/2017    
  • Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer. (Du M, Giridhar KV, Tian Y, Tschannen MR, Zhu J, Huang CC, Kilari D, Kohli M, Wang L) Oncotarget 2017 Sep 08;8(38):63703-63714 PMID: 28969022 PMCID: PMC5609954 10/04/2017    
  • Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm. (Raychaudhuri R, Riese MJ, Bylow K, Burfeind J, Mackinnon AC, Tolat PP, Iczkowski KA, Kilari D) Clin Genitourin Cancer 2017 10;15(5):e897-e901 PMID: 28645484 06/25/2017       2 Citations
  • Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. (Hoang DT, Iczkowski KA, Kilari D, See W, Nevalainen MT) Oncotarget 2017 Jan 10;8(2):3724-3745 PMID: 27741508 PMCID: PMC5356914 10/16/2016    
  • Applications of Extracellular RNAs in Oncology. (Thompson JR, Zhu J, Kilari D, Wang L) Mol Diagn Ther 2017 02;21(1):1-11 PMID: 27688207 10/01/2016       1 Citations
  • Case Report: Spironolactone Withdrawal Associated With a Dramatic Response in a Patient With Metastatic Castrate-Resistant Prostate Cancer. (Flynn T, Guancial EA, Kilari M, Kilari D) Clin Genitourin Cancer 2017 02;15(1):e95-e97 PMID: 27641657 09/20/2016       3 Citations
  • Gaps in nutritional research among older adults with cancer. (Presley CJ, Dotan E, Soto-Perez-de-Celis E, Jatoi A, Mohile SG, Won E, Alibhai S, Kilari D, Harrison R, Klepin HD, Wildes TM, Mustian K, Demark-Wahnefried W) J Geriatr Oncol 2016 07;7(4):281-92 PMID: 27197919 PMCID: PMC4969118 05/21/2016       5 Citations
  • Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting. (Kilari D, Soto-Perez-de-Celis E, Mohile SG, Alibhai SM, Presley CJ, Wildes TM, Klepin HD, Demark-Wahnefried W, Jatoi A, Harrison R, Won E, Mustian KM) J Geriatr Oncol 2016 07;7(4):293-304 PMID: 27197916 PMCID: PMC4969104 05/21/2016       11 Citations
  • Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer. (Guancial EA, Kilari D, Xiao GQ, Abu-Farsakh SH, Baran A, Messing EM, Kim ES) PLoS One 2016;11(5):e0155503 PMID: 27187160 PMCID: PMC4871463 05/18/2016       3 Citations
  • Role of copper transporters in platinum resistance. (Kilari D, Guancial E, Kim ES) World J Clin Oncol 2016 Feb 10;7(1):106-13 PMID: 26862494 PMCID: PMC4734932 02/11/2016    
  • Copper Transporter-CTR1 Expression and Pathological Outcomes in Platinum-treated Muscle-invasive Bladder Cancer Patients. (Kilari D, Iczkowski KA, Pandya C, Robin AJ, Messing EM, Guancial E, Kim ES) Anticancer Res 2016 Feb;36(2):495-501 PMID: 26851002 02/07/2016       15 Citations
  • Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer. (Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L) Oncotarget 2015 Jun 30;6(18):16411-21 PMID: 25915538 PMCID: PMC4599278 04/29/2015       21 Citations
  • How we treat early systemic prostate cancer in older men. (Kilari D, Dale W, Mohile SG) J Geriatr Oncol 2014 Oct 01;5(4):337-42 PMID: 25248671 09/25/2014       5 Citations
  • Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer. (Kim ES, Tang X, Peterson DR, Kilari D, Chow CW, Fujimoto J, Kalhor N, Swisher SG, Stewart DJ, Wistuba II, Siddik ZH) Lung Cancer 2014 Jul;85(1):88-93 PMID: 24792335 PMCID: PMC4090351 05/06/2014       27 Citations
  • Hemophagocytic lymphohistiocytosis masquerading as progressive chronic lymphocytic leukemia. (Kilari D, Venci N, Friedberg J, Bennett JM) Leuk Res Rep 2013;2(1):4-6 PMID: 24371766 PMCID: PMC3850386 12/29/2013    
  • An observational study of plasma vascular endothelial growth factors (VEGF) A and D expression in non-localized prostate cancer. (Verdoorn BP, Feng C, Ricke WA, Sahasrabudhe DM, Kilari D, Kohli M) J Mens Health 2012 Sep 01;9(3):182-189 PMID: 24416090 PMCID: PMC3886726 09/01/2012    
  • Management of cancer in the older adult. (Kilari D, Mohile SG) Clin Geriatr Med 2012 Feb;28(1):33-49 PMID: 22326034 02/14/2012       7 Citations
  • Inpatient management of sickle cell pain: a 'snapshot' of current practice. (Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)) Am J Hematol 2012 Mar;87(3):333-6 PMID: 22231150 PMCID: PMC5047515 01/11/2012       19 Citations
  • Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial. (Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP, Sickle Cell Disease Clinical Research Network (SCDCRN)) Contemp Clin Trials 2012 Mar;33(2):291-7 PMID: 22155024 PMCID: PMC3577351 12/14/2011       38 Citations
  • Last update: 02/23/2019
    jenkins-FCD Prod-321 98992d628744e349846c2f62ac68f241d7e1ea70